Q: What are your thoughts on Valeant? Based on Bill Ackman's valuation, it seems that the market is drastically undervaluing this company.
Link to his presentation: http://assets.pershingsquareholdings.com/2014/09/Investor-Call-re-Valeant-Pharmaceuticals.pdf
Link to his presentation: http://assets.pershingsquareholdings.com/2014/09/Investor-Call-re-Valeant-Pharmaceuticals.pdf